Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Tuberculosis Therapeutics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Disease Type (Active Tuberculosis, Latent Tuberculosis)
5.2.2. By Therapy (First Line Therapy, Second Line Therapy)
5.2.3. By Route of Administration (Oral, Parenteral, Others)
5.2.4. By Dosage Form (Tablets, Capsules, Injection, Others)
5.2.5. By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)
5.2.6. By Region
5.2.7. By Company (2022)
5.3. Product Map
5.3.1. By Disease Type
5.3.2. By Therapy
5.3.3. By Route of Administration
5.3.4. By Dosage Form
5.3.5. By Distribution Channel
5.3.6. By Region
6. North America Tuberculosis Therapeutics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Disease Type
6.2.2. By Therapy
6.2.3. By Route of Administration
6.2.4. By Dosage Form
6.2.5. By Distribution Channel
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States Tuberculosis Therapeutics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Disease Type
6.3.1.2.2. By Therapy
6.3.1.2.3. By Route of Administration
6.3.1.2.4. By Dosage Form
6.3.1.2.5. By Distribution Channel
6.3.2. Canada Tuberculosis Therapeutics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Disease Type
6.3.2.2.2. By Therapy
6.3.2.2.3. By Route of Administration
6.3.2.2.4. By Dosage Form
6.3.2.2.5. By Distribution Channel
6.3.3. Mexico Tuberculosis Therapeutics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Disease Type
6.3.3.2.2. By Therapy
6.3.3.2.3. By Route of Administration
6.3.3.2.4. By Dosage Form
6.3.3.2.5. By Distribution Channel
7. Europe Tuberculosis Therapeutics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Disease Type
7.2.2. By Therapy
7.2.3. By Route of Administration
7.2.4. By Dosage Form
7.2.5. By Distribution Channel
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. France Tuberculosis Therapeutics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Disease Type
7.3.1.2.2. By Therapy
7.3.1.2.3. By Route of Administration
7.3.1.2.4. By Dosage Form
7.3.1.2.5. By Distribution Channel
7.3.2. Germany Tuberculosis Therapeutics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Disease Type
7.3.2.2.2. By Therapy
7.3.2.2.3. By Route of Administration
7.3.2.2.4. By Dosage Form
7.3.2.2.5. By Distribution Channel
7.3.3. United Kingdom Tuberculosis Therapeutics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecasty
7.3.3.2.1. By Disease Type
7.3.3.2.2. By Therapy
7.3.3.2.3. By Route of Administration
7.3.3.2.4. By Dosage Form
7.3.3.2.5. By Distribution Channel
7.3.4. Italy Tuberculosis Therapeutics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Disease Type
7.3.4.2.2. By Therapy
7.3.4.2.3. By Route of Administration
7.3.4.2.4. By Dosage Form
7.3.4.2.5. By Distribution Channel
7.3.5. Spain Tuberculosis Therapeutics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Disease Type
7.3.5.2.2. By Therapy
7.3.5.2.3. By Route of Administration
7.3.5.2.4. By Dosage Form
7.3.5.2.5. By Distribution Channel
8. Asia-Pacific Tuberculosis Therapeutics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Disease Type
8.2.2. By Therapy
8.2.3. By Route of Administration
8.2.4. By Dosage Form
8.2.5. By Distribution Channel
8.2.6. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Tuberculosis Therapeutics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Disease Type
8.3.1.2.2. By Therapy
8.3.1.2.3. By Route of Administration
8.3.1.2.4. By Dosage Form
8.3.1.2.5. By Distribution Channel
8.3.2. India Tuberculosis Therapeutics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Disease Type
8.3.2.2.2. By Therapy
8.3.2.2.3. By Route of Administration
8.3.2.2.4. By Dosage Form
8.3.2.2.5. By Distribution Channel
8.3.3. Japan Tuberculosis Therapeutics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Disease Type
8.3.3.2.2. By Therapy
8.3.3.2.3. By Route of Administration
8.3.3.2.4. By Dosage Form
8.3.3.2.5. By Distribution Channel
8.3.4. South Korea Tuberculosis Therapeutics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Disease Type
8.3.4.2.2. By Therapy
8.3.4.2.3. By Route of Administration
8.3.4.2.4. By Dosage Form
8.3.4.2.5. By Distribution Channel
8.3.5. Australia Tuberculosis Therapeutics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Disease Type
8.3.5.2.2. By Therapy
8.3.5.2.3. By Route of Administration
8.3.5.2.4. By Dosage Form
8.3.5.2.5. By Distribution Channel
9. South America Tuberculosis Therapeutics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Disease Type
9.2.2. By Therapy
9.2.3. By Route of Administration
9.2.4. By Dosage Form
9.2.5. By Distribution Channel
9.2.6. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Tuberculosis Therapeutics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Disease Type
9.3.1.2.2. By Therapy
9.3.1.2.3. By Route of Administration
9.3.1.2.4. By Dosage Form
9.3.1.2.5. By Distribution Channel
9.3.2. Argentina Tuberculosis Therapeutics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Disease Type
9.3.2.2.2. By Therapy
9.3.2.2.3. By Route of Administration
9.3.2.2.4. By Dosage Form
9.3.2.2.5. By Distribution Channel
9.3.3. Colombia Tuberculosis Therapeutics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Disease Type
9.3.3.2.2. By Therapy
9.3.3.2.3. By Route of Administration
9.3.3.2.4. By Dosage Form
9.3.3.2.5. By Distribution Channel
10. Middle East and Africa Tuberculosis Therapeutics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Disease Type
10.2.2. By Therapy
10.2.3. By Route of Administration
10.2.4. By Dosage Form
10.2.5. By Distribution Channel
10.2.6. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Tuberculosis Therapeutics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Disease Type
10.3.1.2.2. By Therapy
10.3.1.2.3. By Route of Administration
10.3.1.2.4. By Dosage Form
10.3.1.2.5. By Distribution Channel
10.3.2. Saudi Arabia Tuberculosis Therapeutics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Disease Type
10.3.2.2.2. By Therapy
10.3.2.2.3. By Route of Administration
10.3.2.2.4. By Dosage Form
10.3.2.2.5. By Distribution Channel
10.3.3. UAE Tuberculosis Therapeutics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Disease Type
10.3.3.2.2. By Therapy
10.3.3.2.3. By Route of Administration
10.3.3.2.4. By Dosage Form
10.3.3.2.5. By Distribution Channel
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Global Tuberculosis Therapeutics Market: SWOT Analysis
14. Porter’s Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Business Overview
15.2. Service Offerings
15.3. Recent Developments
15.4. Key Personnel
15.5. SWOT Analysis
15.5.1. AstraZeneca
15.5.2. Johnson & Johnson
15.5.3. Eli Lilly And Company
15.5.4. Mylan N.V.
15.5.5. Teva Pharmaceutical Industries Ltd.
15.5.6. Sanofi SA
15.5.7. Novartis AG
15.5.8. Sun Pharmaceutical Industries Ltd.
15.5.9. Pfizer Inc.
16. Strategic Recommendations